Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02251886
Other study ID # Moxibustion and breech
Secondary ID
Status Completed
Phase N/A
First received September 25, 2014
Last updated September 26, 2014
Start date January 2003
Est. completion date September 2014

Study information

Verified date September 2014
Source Herning Hospital
Contact n/a
Is FDA regulated No
Health authority Denmark: The National Committee on Health Research Ethics
Study type Interventional

Clinical Trial Summary

Moxibustion was tested for version of a breech position in singleton pregnancies. The women were randomized in week 32 to either moxibustion on acupuncture point Bl 67 daily in 15-20 minutes or no moxibustion. In week 36-37 the fetal position was checked and external cephalic version was offered for those still in breech position. The randomization was stratified for primigravida and multiparae separately. The randomization was made with a random number even and odd numbers indicating moxibustion or not. The randomization result was hidden in a sealed, non-transparent envelope on the obstetrical department and drawn when the woman gave informed consent to the study.


Description:

Moxibustion was tested for version of a breech position in singleton pregnancies.

The women were randomized in week 32 to either moxibustion on acupuncture point Bl 67 daily in 15-20 minutes or no moxibustion. In week 36-37 the fetal position was checked and external cephalic version was offered for those still in breech position. The randomization was stratified for primigravida and multiparae separately. The randomization was made with a random number even and odd numbers indicating moxibustion or not. The randomization result was hidden in a sealed, non-transparent envelope on the obstetrical department and drawn when the woman gave informed consent to the study.

Sample size calculation gave 45 women in each group, based on alfa 0.05 and beta 20 under condition of a 30 % effect of moxibustion vs. 20 % of spontaneous version in the control group in primiparae and 60 % in multiparae, respectively. Thus, 4 times 45 women in each group were sought. Only women who had performed three treatments were judged under the principle of intention to treat.

Exclusion criteria at inclusion in week 32 was bleeding in 2nd and 3rd trimester, placenta insufficiency, cervical shortening, premature rupture of membranes, preeclampsia, elevated blood pressure, pelvic insufficiency, low placental position, uterine malformations, former uterine corrective surgery and known fetal morbidity


Recruitment information / eligibility

Status Completed
Enrollment 206
Est. completion date September 2014
Est. primary completion date January 2011
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- pregnant women with singleton breech position of their babies

Exclusion Criteria:

- vaginal bleeding in 2nd and 3rd trimester, placental insufficiency, cervical shortening, premature rupture of membranes, preeclampsia, high blood pressure, pelvic insufficiency, low placental position, placenta praevia, uterine malformations, previous corrective uterine surgery, known fetal morbidity

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Other:
Moxibustion in primiparae
Moxibustion at acupuncture point Bl 67 daily for 15-20 minutes for 3-4 weeks in multiparae
Moxibustion in multiparae
Moxibustion at acupuncture point Bl 67 daily for 15-20 minutes for 3-4 weeks in multiparae

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Herning Hospital

Outcome

Type Measure Description Time frame Safety issue
Primary Version of fetal breech position to cephalic position Moxibustion added to acupuncture point Bl 67 daily for 15-20 minutes, version occuring within the four weeks of treatment 4 weeks No